RGTARGENT BIOPHARMA LIMITEDMarket sensitive

U.S. In Vivo Study Supports ArtemiC Efficacy

Date and time
Announcement type
Company Update

More from Health Care

RGTCompany Update29 September 2026

Argent BioPharma (ASX: RGT) Licences NLC Antiviral Portfolio

More News

SKKMergers & Acquisitions17 September 2026

Stakk (ASX: SKK) Completes US$63 Million ParaScript Acquisition